Charles Handfield Wyatt MD
Cardiovascular Surgery
Previous Chief Medical Officer HCA Regional Med Ctr
Join to view full profile
3715 Dauphin StSte 7AMobile, AL 36608
Phone+1 251-410-4001
Fax+1 251-410-4002
Dr. Wyatt is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of Miami/Jackson Health SystemFellowship, Thoracic Surgery - Independent, 1991 - 1993
Baylor College of MedicineResidency, Surgery, 1986 - 1991- Baylor College of MedicineClass of 1986
Certifications & Licensure
TX State Medical License 1988 - 2028
FL State Medical License 1993 - 2027
KS State Medical License 2025 - 2027
LA State Medical License 1998 - 2027
AL State Medical License 2020 - 2026
American Board of Thoracic Surgery Thoracic and Cardiac Surgery
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 2 Certification Allscripts Enterprise EHR, Allscripts, 2014, 2016-2017
- CMS Meaningful Use Stage 1 Certification hCare EHR Dashboard for EP v 1.0, HCA Information Technology & Services, Inc., 2014, 2016-2017
- CMS Meaningful Use Stage 1 Certification eClinicalWorks, eClinicalWorks, LLC, 2014, 2016-2017
Publications & Presentations
PubMed
- 21 citationsTargeted renal therapy and contrast-induced nephropathy during endovascular abdominal aortic aneurysm repair: results of a feasibility pilot trial.David E. Allie, Mitchell D. Lirtzman, Charles H. Wyatt, V. Antoine Keller, Elena V. Mitran
Journal of Endovascular Therapy. 2007-08-01 - A review of the early experience with Targeted Renal Therapy™ for renal function preservation during endovascular and surgical treatments for cardiovascular diseaseDavid E. Allie, Chris J. Hebert, Raghotham R. Patlola, Mitchell D. Lirtzman, Charles H. Wyatt
Eurointervention. 2007-05-01 - 18 citationsA safety and feasibility report of combined direct thrombin and GP IIb/IIIa inhibition with bivalirudin and tirofiban in peripheral vascular disease intervention: trea...David E. Allie, Chris J. Hebert, Lirtzman, Charles H. Wyatt, V.A. Keller
The Journal of Invasive Cardiology. 2005-08-01
Professional Memberships
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
